Introduction
============

Obesity is a major risk factor for premature death, with lifestyle playing an important role in the development of comorbidities, such as type 2 diabetes, hypertension, cardiovascular disease, and cancer.[@b1-dmso-6-469] The 2005 estimate from the World Health Organization indicated that more than 1.6 billion adults worldwide were overweight and at least 400 million were obese.[@b2-dmso-6-469] Obesity is a multifactorial disease consisting of genetic, metabolic, and environmental factors. The control of appetite and satiety, as well as energy expenditure and metabolic rate, play a critical role in obesity, and therefore should be considered in the management of overweight and obese individuals.

Ghrelin is an orexigenic peptide produced mainly in the stomach, and in small amounts in the duodenum, jejunum, ileum, colon, placenta, heart, hypothalamic arcuate nucleus, and kidneys.[@b3-dmso-6-469] Both acylated and desacylated ghrelin are found in the bloodstream, with desacylated ghrelin being the most abundant form.[@b4-dmso-6-469] The two forms of ghrelin have different physiological roles and effects, and measurement of total ghrelin concentration may not elucidate the changes in metabolism and body weight regulation caused by these two forms individually.[@b5-dmso-6-469] Acylated ghrelin[@b6-dmso-6-469] (AG) is associated with energy homeostasis and basal metabolic rate, which are contributing factors to the maintenance and/or reduction of weight.[@b7-dmso-6-469] Nonacylated ghrelin is found predominantly (80%--90% of total ghrelin) in the blood and binds to high-density lipoproteins containing different esterases.[@b8-dmso-6-469] Although nonacylated ghrelin is a product of a modification of AG, it does not replace AG in the binding regions in the hypothalamus and pituitary, and shows no activity either on appetite in rats or in humans.[@b9-dmso-6-469]

Research on the association of exercise with food intake suggests that exercise has an impact not only on energy expenditure but also on the regulation of appetite and postexercise energy balance.[@b10-dmso-6-469] Hansen et al[@b11-dmso-6-469] investigated the effects of a weight-loss intervention on obese women, and found increased total ghrelin concentrations following weight loss. Foster-Schubert et al[@b12-dmso-6-469] showed increased total ghrelin concentrations in response to weight loss in postmenopausal women after a 12-month aerobic exercise intervention. Therefore, changes in AG may be associated with the outcomes and success of obesity treatments, since cycling of weight gain and loss could depend on hormonal energy regulation.

Behavioral changes based on dietary therapy and physical exercise have been widely recommended in the management of overweight and obese individuals.[@b1-dmso-6-469],[@b2-dmso-6-469] Studies have suggested that a 5%--10% loss of total body mass should be sufficient to produce beneficial effects in obese subjects. Recent studies have shown time-dependent beneficial effects of diet and physical training associated with changes in ghrelin concentrations in obese subjects.[@b1-dmso-6-469] Therefore, the aim of this study was to investigate the effects of a 5% reduction in total body mass on biochemical parameters, resting metabolic rate (RMR), and AG concentration in grade 1 obese subjects undergoing a diet- or diet plus exercise-induced weight-loss program.

Materials and methods
=====================

The program was a group-based intervention designed to produce a 5% reduction in body weight, nested in a previous study[@b13-dmso-6-469] For sample size, we used previous studies regarding AG,[@b10-dmso-6-469] and the calculation was made using Altman's nomogram, with the following settings: power was set at 80%, α was set at 0.5, and the standardized difference was 0.89, resulting in a sample size of 18 subjects, including 20% for future losses.[@b14-dmso-6-469] The sample consisted of 22 adult subjects (16 women and six men) who were selected from the outpatient clinic of Hospital de Clínicas de Porto Alegre, Brazil. Subjects were randomized into two intervention groups: diet group (DG; n=11, three men) and diet-plus-exercise group (D+EG; n=11, three men). However, at the end of the program, nine subjects from each group were analyzed for reasons that are explained in [Figure 1](#f1-dmso-6-469){ref-type="fig"}. All participants had a sedentary lifestyle, were nonsmokers, aged 20--40 years, and classified as grade 1 obese (body mass index \[BMI\] 30--34.9 kg/m^2^), nondiabetic, and without any major comorbidities. Treatment duration was recorded individually as the time between the initiation of treatment and achievement of a 5% body mass reduction. The study was approved by the local ethics committee (institutional review board equivalent), and was conducted in accordance with the provisions of the Declaration of Helsinki. Written informed consent was obtained from all participants.

Diet
----

A balanced diet (60% carbohydrate, 15% protein, and 25% fat of the total energy value) was prescribed to all participants. The diet followed the guidelines established by the Brazilian Society of Cardiology[@b15-dmso-6-469] Total energy value was calculated based on RMR and physical activity), as follows: RMR × physical activity -- 500--1,000 kcal/day The subjects were assessed every 14 days to monitor body weight and adherence to diet, until a 5% body mass reduction was achieved.

Exercise
--------

The training program consisted of 40-minute exercise sessions on a stationary bicycle, three times a week (on alternate days), at 70% of heart rate (HR) reserve, which was calculated according to Karvonen et al[@b16-dmso-6-469]: HR~training~ = (HR~max~-HR~rest~) × 0.70+HR~rest~. HR during training was monitored using HR monitors (S100; Polar, Kempele, Finland). Participants failing to attend at least 75% of the training program or three consecutive intervention sessions were considered dropouts.

Protocol application
--------------------

The subjects were randomly divided into two groups of different interventions: the DG group and the D+EG group. A qualified exercise scientist and qualified nutritionist respectively prescribed the training and diet. Every 15 days, all subjects returned to the laboratory to carry out control measures of body weight, height, and waist and to adjust the menu if necessary. The subjects randomized to the D+EG group came to the laboratory three times a week to conduct supervised physical training with the coaches.

Resting metabolic rate
----------------------

Subjects were asked to refrain from moderate- or high-intensity physical activities for 24 hours prior to testing, and were also asked to fast for 12 hours and sleep for at least 8 hours the night before testing. In addition, all participants were instructed not to drink alcohol or caffeine or take any kind of medication without consulting the researchers. All tests were performed between 7:30 and 9:30 am in a quiet, temperature-controlled room (20°C--25°C) under artificial illumination. The protocol consisted of 10 minutes' bed rest in the supine position followed by assessment of expired gas samples for 30 minutes. A computerized gas analyzer (CPX/D; MGC Diagnostics, Saint Paul, MN, USA) was used to determine oxygen uptake (VO~2~) and carbon dioxide output (VCO~2~). To calculate RMR, the first 10 minutes of gas uptake were discarded and data from the final 20 minutes of collection were used to calculate mean values over the test period.[@b17-dmso-6-469] The following formula was used to obtain the values of kcal/day: (\[3.9 × VO~2~\]+\[1.1 × VCO~2~\]) × 1,440.[@b17-dmso-6-469]

Maximal oxygen consumption
--------------------------

The maximal oxygen consumption (VO~2max~) protocol consisted of incremental exercise on a stationary bicycle. An initial 3-minute warm-up at 25 W and 70--80 rpm was followed by incremental increases of 25 W every 60 seconds through the end of the test. The following criteria were used to determine maximal capacity for oxygen consumption at the test: the subject reached volitional fatigue, respiratory exchange ratio (RER) ≥1.15, HR~test~ ≥95% of age-predicted maximum HR (220 -- age), and/or a plateau in oxygen consumption with increasing load.[@b18-dmso-6-469] Oxygen consumption was determined using the CPX/D computerized gas analyzer, which was calibrated before each test.

Acylated ghrelin
----------------

A 5 mL blood sample was collected from the antecubital area and immediately transferred to tubes containing ethylenediaminetetraacetic acid and 10 μL of 4-(hydroxymercury) benzoic acid sodium salt to avoid deacylation of ghrelin by proteolysis. The sample was centrifuged at 3,500 rpm for 10 minutes at 4°C.[@b10-dmso-6-469] Plasma was separated, and 100 mL of hydrochloric acid was added for every 1 mL of plasma. The samples were centrifuged again at 3,500 rpm for 5 minutes at 4°C, and the supernatant was aliquoted into two vials and frozen at −80°C for later analysis. Plasma AG concentrations were determined by enzyme-linked immunosorbent assay (SPI BIO, Montigny le Bretonneux, France). To eliminate interassay variation, all samples from each participant were analyzed in the same assay. The within-batch coefficient of variation was 2.1%.

Blood analyses
--------------

Glucose was measured using a hexokinase assay with an enzymatic ultraviolet method. Glucose were assessed in an Advia (Bayer, Leverkusen, Germany) automated analyzer. Insulin was measured by electrochemiluminescence (Elecsys®; Roche, Basel, Switzerland).

Body composition
----------------

Anthropometric assessments were performed according to the recommendations of the International Society for the Advancement of Kinanthropometry.[@b19-dmso-6-469] The Durnin and Womersley[@b20-dmso-6-469] protocol was chosen, which takes into account a subject's body mass, triceps, biceps, and subscapular and iliac crest skin folds. Subjects were measured and weighed while wearing light indoor clothing, using a calibrated anthropometer and a digital scale. BMI was calculated as body mass (kg) divided by height squared (m^2^).

Statistical analysis
--------------------

The Shapiro--Wilk test was used to verify the normal distribution of data, and the Levene test to assess the homogeneity of variances. The intervention groups were compared for anthropometric, metabolic, and biochemical characteristics using Student's *t*-test for independent samples. Student's *t*-test for paired samples was used to identify significant intragroup differences between points in time. For intergroup analyses, variable deltas were calculated and verified using Student's *t*-test for independent samples. We applied a covariance test to check for possible interferences of sex and time on the variables. All results were expressed as means ± standard deviation, unless otherwise stated. All statistical tests were two-sided, and the significance level was set at *P*\<0.05. Data were analyzed using SPSS version 17.0 for Windows (IBM, Armonk, NY, USA).

Results
=======

A total of 22 subjects participated in our weight-loss program and were equally divided into two intervention groups: DG or D+EG. Both groups were considered homogeneous at baseline. However, for data analysis, 18 individuals were considered, nine in each group, as explained in [Figure 1](#f1-dmso-6-469){ref-type="fig"}. The pre- and postintervention anthropometric and metabolic data of all participants are described in [Table 1](#t1-dmso-6-469){ref-type="table"}. Both groups achieved the targeted 5% body mass reduction, but treatment duration was longer in the DG (85.1±26.5 days vs 74.1±26.0 days in the D+EG). There were significant differences in pre- and postintervention body mass (kg) between groups. The reduction in total body mass induced a significant decrease in body fat percentage (38.9%±5.26% vs 36.9%±5.21%, *P*≤0.001; and 37.6%±5.1% vs 35.0%±5.5%, *P*≤0.01) and fat mass (38.1±4.1 vs 33.9±3.4 kg, *P*≤0.001; and 34.4±3.54 vs 30.4±3.33 kg, *P*≤0.01) in the DG and D+EG, respectively ([Table 1](#t1-dmso-6-469){ref-type="table"}). RMR (kcal/day) did not increase after treatment in the DG; however, RMR increased after treatment in the D+EG (1,363.6±379.9 vs 1,585.3±171.4 kcal/day, *P*≤0.008) ([Figure 2](#f2-dmso-6-469){ref-type="fig"}). There were a positive correlation between RMR and AG for DG pretreatment (0.82, *P*≤0.04). After treatment, we found an increased ghrelin concentration, and this correlation was lower (0.67, *P*≤0.04).

In the D+EG, a significant difference was found only in AG concentration (54.4±25.3 vs 33.2±19.1 pg/mL, *P*≤0.01) ([Table 1](#t1-dmso-6-469){ref-type="table"}). Change values were determined for both groups to demonstrate the effects of treatment. This analysis revealed differences in treatment effects on AG concentrations between groups (43.5±28 vs 19.2±10 pg/mL, *P*≤0.05), with a 15.4% increase in the DG and a 39% decrease in the D+EG. Between-group differences in AG values and the effects of treatment in both groups are shown in [Figure 3](#f3-dmso-6-469){ref-type="fig"}.

Discussion
==========

The interventions with diet or diet plus exercise in this study produced different effects on energy metabolism and AG, improving health parameters like BMI evaluated in obese subjects. In the present study, diet- and diet plus exercise-induced weight loss had no significant effects on glucose or insulin levels after treatment. Although these results were not statistically significant, reductions in glucose and insulin levels may be clinically relevant in the management of insulin resistance. A possible explanation lies in the duration of treatment to achieve the targeted 5% body mass reduction, which was different between groups (DG 85 days vs D+EG 74 days).[@b21-dmso-6-469]

In the present study, diet- and diet plus exercise-induced weight loss had no significant effects on glucose or insulin levels after treatment. A possible explanation lies in the duration of treatment to achieve the targeted 5% body mass reduction, which was different between groups (DG 85 days vs D+EG 74 days).

Fat mass decreased significantly in both groups after treatment. In addition, diet-induced weight loss produced a significant reduction in fat-free mass. These results suggest that exercise may help maintain muscle mass by inducing physiological changes that increase muscle mass or decrease the potential of diet to have an influence on muscle tissue. Diet plus exercise-induced weight loss also significantly increased RMR, which may be related to the maintenance of muscle mass observed in this group. Because fat-free mass did not decrease significantly in this group, these results may indicate that physical exercise has an effect on RMR values in obese subjects when in combination with a weight-reduction diet. In turn, participants assigned to diet alone showed no differences in RMR after treatment, although previous studies have suggested that a reduced-calorie diet may lead to a decrease in muscle mass, promoting RMR reduction.[@b22-dmso-6-469] Nevertheless, RMR does not only depend on muscle mass and may be influenced by several factors, including fat-free mass, body surface area, fat mass, age, and sex.[@b23-dmso-6-469] We found a positive correlation between RMR and AG for DG pretreatment (0.82). After treatment, we found an increased ghrelin concentration, and this correlation was lower (0.67). This positive relationship of AG and basal metabolic rate is supported by Marzullo et al,[@b6-dmso-6-469] who found a positive relationship between AG and resting energy expenditure in obese subjects, suggesting that ghrelin secretion is only decreased with the impairment of energy expenditure. Since RMR was not statistically different for the DG after treatment, we could speculate that increased ghrelin could be related to a lower RMR when comparing this result with the D+EG, where this correlation was not found, which could be justified for other metabolic or body-composition changes that influenced the increase in RMR regardless of ghrelin concentrations, such as fat-free mass or total surface area.

Recent studies have suggested that increased AG concentrations observed in obese subjects after diet-induced weight reduction are related to lower energy reserves, mainly adipose tissue.[@b11-dmso-6-469] Increased AG concentrations may also be associated with reports of increased hunger during treatment and difficulty in reducing food intake and losing weight. In a recent study by our group, a single session of aerobic exercise was able to reduce acutely AG concentrations and hunger in eutrophic subjects compared to resting controls.[@b10-dmso-6-469] Similarly, Broom et al[@b24-dmso-6-469] found reduced AG concentrations in normal-weight individuals undergoing an acute session of moderate-intensity aerobic exercise (60% VO~2max~) compared with resting controls. A few studies have evaluated the effects of chronic exercise on obese subjects. King et al[@b25-dmso-6-469] showed that caloric restriction induced a significant increase in AG concentrations compared with baseline values, whereas exercise promoted opposite effects. Our results demonstrated that a 5% diet plus exercise-induced weight loss was able to significantly reduce AG concentrations in obese individuals. Our analysis of delta values revealed a 15.4% increase in AG concentrations in subjects assigned to diet alone and a 39% decrease in AG concentrations in those assigned to the D+EG. Likewise, Scheid et al[@b26-dmso-6-469] found similar results after a 3-month aerobic training in eutrophic subjects who lost weight. Ravussin et al,[@b27-dmso-6-469] however, found no significant differences in plasma ghrelin concentration in monozygotic twins under different diet and physical exercise treatments. Similar to our results, Hansen et al[@b11-dmso-6-469] found increased total ghrelin concentrations following weight reduction in obese women attending a diet-induced weight-loss program. However, our findings contrast with those reported by Foster-Schubert et al,[@b12-dmso-6-469] who found increased total ghrelin concentrations after an exercise program. We can speculate that exercise training combined with dietary intervention, rather than diet therapy alone, promotes different effects on AG concentrations when associated with weight loss, reducing AG concentrations. Also, AG concentrations may respond differently than total ghrelin, thus affecting the AG and desacylated ghrelin ratio. The reduction in AG observed in our group attending the diet-plus-exercise intervention may be related to the effects of aerobic exercise promoted by muscle response, ie, growth-hormone release.[@b28-dmso-6-469] According to St-Pierre et al,[@b29-dmso-6-469] obese individuals with some degree of insulin resistance have lower AG values when compared with normal-weight subjects. Krekoukia et al[@b30-dmso-6-469] showed that aerobic exercise was able to reduce insulin resistance and reduce or even prevent the deleterious effects of diabetes mellitus. Insulin and acylated ghrelin showed a positive correlation only after treatment for D+EG (*r*=0.80). To our knowledge, this is the first time that a positive correlation was found after a diet-with-exercise intervention. We could only speculate that the change in BMI after the intervention affected the modulation on insulin and ghrelin in obese subjects, and future studies should investigate this relationship further. The effect of AG on food intake suggests a potential role of AG in the body's return to homeostasis following a reduction in body mass. Thus, the combination of dietary treatment and exercise training may promote homeostasis and restore AG values to normal physiological levels. Therefore, it could maintain RMR in healthier levels.

The present study has some limitations. Although our sample size matches the statistical power for our main variable (AG) we could argue that it was small to present intergroup differences for such variables as insulin and glucose. Regarding our anthropometric data, we used a two-component measurement protocol, which is better suited for diagnosis but it is not the ideal for clinical approaches, since the changes in some tissues cannot be measured by this method, mainly differences in body water. Also, we could not measure hormones such as adiponectin, leptin, or growth hormone, which might be able to provide a better understanding of the ghrelin metabolism and mechanisms related to physical training and RMR regulation.

Conclusion
==========

Our findings showed that a dietary intervention associated with exercise training was able to reduce AG concentrations and increase RMR in grade 1 obese subjects, factors considered essential to ensure the benefits of a weight-loss program. Therefore, we believe that successful treatment of obesity should consist of a comprehensive approach involving diet and exercise intervention. In addition, future research is encouraged to further investigate treatment options that can effectively combat obesity.
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![Flow diagram of patient recruitment and randomization.](dmso-6-469Fig1){#f1-dmso-6-469}

![Pre- and postintervention basal metabolic rate values.\
**Notes:** \*Statistically significant difference (*P*\<0.05, *r*=0.547) between pre- and postintervention values for the diet-plus-exercise group. Two-way ANOVA with Bonferroni's post hoc test.](dmso-6-469Fig2){#f2-dmso-6-469}

![Comparison of acylated ghrelin (AG) values (pg/mL) between the diet group (DG) and diet-plus-exercise group (D+EG) following a 5% body mass reduction (absolute values and deltas).\
**Notes:** \*Statistically significant reduction (*P*\<0.05, *r*=0.539) in AG concentrations comparing DG and D+EG absolute values (pg/mL) and delta values of variation (%).](dmso-6-469Fig3){#f3-dmso-6-469}

###### 

Pre- and postintervention anthropometric, metabolic, and biochemical parameters of subjects participating in a diet- or diet plus exercise-induced weight-loss program

                                 Diet group (n=9)   Diet + exercise group (n=9)                                        
  ------------------------------ ------------------ ------------------------------------------------------ ----------- ------------------------------------------------------
  Age (years)                    30.75±7.7          30.98±7.7                                              31.37±5.2   31.57±5.2
  Height (m)                     1.66±0.07          1.66±0.07                                              1.69±0.08   1.69±0.08
  Body mass (kg)                 98.6±9.2           93 2±8.1[\*](#tfn1-dmso-6-469){ref-type="table-fn"}    92.7±11.9   87.9±10.7[\*](#tfn1-dmso-6-469){ref-type="table-fn"}
  BMI (kg/m^2^)                  35.8±1.2           33.8±1.4                                               32.5±1.4    30.8±1.7
  \% BMI change                  --                 −4.77                                                  --          −5.60
  Fat (%)                        38.9±5.26          36.9±5.21[\*](#tfn1-dmso-6-469){ref-type="table-fn"}   37.6±5.1    35.0±5.5[\*](#tfn1-dmso-6-469){ref-type="table-fn"}
  Fat mass (kg)                  38.1±4.1           33.9±3.4[\*](#tfn1-dmso-6-469){ref-type="table-fn"}    34.4±3.54   30.4±3.33[\*](#tfn1-dmso-6-469){ref-type="table-fn"}
  \% fat mass change             --                 −11.0                                                  --          −11.62
  Fat-free mass (kg)             61.4*±*10          59.3±9.5[\*](#tfn1-dmso-6-469){ref-type="table-fn"}    58±11.6     57.4±11.4
  \% fat-free mass change        --                 −3.42[\*](#tfn1-dmso-6-469){ref-type="table-fn"}       --          −1.03
  VO~2max~ (mL/kg/minute)        23.4±3.4           24.2±5.09                                              24.4±7.5    27.0±7.5
  HR~max~ (bpm)                  181±13.6           176.9±12.0                                             177.7±7.4   175.4±12.6
  Glucose (mg/dL)                90.1±8.2           86.7±9.3                                               97.5±10.4   93.1±6.5
  Insulin (μIU/mL)               19.3±6.8           13.7±5.8                                               16.8±6.4    13.2±5.9
  Acylated ghrelin (pg/mL)       36.8±23.3          43.5±28.8                                              54.4±25.3   33.2±19.1[\*](#tfn1-dmso-6-469){ref-type="table-fn"}
  Intervention duration (days)   --                 85.1±26.5                                              --          74.1±26.0

**Notes:**

*P*\<0.05 intragroup difference found. Values are expressed as means ± standard deviation. Two-way analysis of variance with Bonferroni's post hoc test and Student's *t*-test for paired samples were used to compare anthropometric values and postintervention values between groups.

**Abbreviations:** BMI, body mass index; HR~max~, maximal heart rate; VO~2max~, maximal oxygen uptake.
